These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 24239912)
1. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity. Wang Z; Qian H; Yiu SM; Sun J; Zhu G J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912 [TBL] [Abstract][Full Text] [Related]
2. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor. Wang B; Qian H; Yiu SM; Sun J; Zhu G Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells. Pavlović M; Tadić A; Gligorijević N; Poljarević J; Petrović T; Dojčinović B; Savić A; Radulović S; Grgurić-Šipka S; Aranđelović S J Inorg Biochem; 2020 Sep; 210():111155. PubMed ID: 32768729 [TBL] [Abstract][Full Text] [Related]
4. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
5. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors. Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115 [TBL] [Abstract][Full Text] [Related]
6. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors. de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342 [TBL] [Abstract][Full Text] [Related]
7. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer. Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands. Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875 [TBL] [Abstract][Full Text] [Related]
9. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis. Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361 [TBL] [Abstract][Full Text] [Related]
10. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells. Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors. Xu Z; Li C; Zhou Q; Deng Z; Tong Z; Tse MK; Zhu G Inorg Chem; 2019 Dec; 58(23):16279-16291. PubMed ID: 31738050 [TBL] [Abstract][Full Text] [Related]